The Korean Journal of Food And Nutrition (한국식품영양학회지)

The Korean Society of Food and Nutrition (한국식품영양학회)
권호 표지

The Effects of Angelica keiskei Koidzumi and Turmeric Extract Supplementation on the Blood Lipids, and Antioxidant and Inflammatory Markers in Hypercholesterolemic Adults in Korea

고콜레스테롤혈증 성인에서 울금과 명일엽 복합 추출물의 복용에 따른 혈중지질, 항산화 및 염증 관련 지표의 변화

  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study investigated the effects of Angelica keiskei Koidzumi and turmeric extract supplementation(ATE) on blood lipids, antioxidant and inflammatory markers in 35 hypercholesterolemic Korean adults with high blood cholesterol levels (serum total cholesterol$\geq200mg/d{\ell}$ or LDL-cholesterol$\geq130mg/d{\ell}$). They received ATE(n=21, 14 females and 7 males) or placebo(control group, n=14, 11 females and 3 males) for 4 weeks. There was no significant change in serum total cholesterol, LDL-cholesterol and HDL-cholesterol levels after ATE supplementation in the both groups. However, the LDLcholesterol: HDL-cholesterol ratio(LPH) was significantly decreased and both serum prostagrandin E2(PGE2) levels were significantly decreased in those receiving ATE. No significant changes were evident in interleukin(IL)-$1\beta$, IL-6, IL-8, 8-isoprostane, malondialehyde, total antioxidant capacity and oxidized-LDL. These results suggest that complex extract of Angelica keiske and turmeric has the potential to decrease cardiovascular risk by reducing LPH and inflammatory mediator $PGE_2$ in hypercholesterolemic adults.

Keywords

References

  1. Ammon HP, Wahl MA. 1991. Pharmacology of Curcuma longa. Planta Med 57:1-7 https://doi.org/10.1055/s-2006-960004
  2. Arafa HM. 2005. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 11:BR228-234
  3. Benzie IF, Strain JJ. 1996. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 239:70-76 https://doi.org/10.1006/abio.1996.0292
  4. Bonnie Ky, Anne Burke, Sotirios Tsimikas, Megan L. Wolfe, Mahlet G. Tadesse, Philippe O. Szapary, Joseph L. Witztum, Garret A. FitzGerald, Daniel J. Rader. 2008. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. J Am Coll Cardiol 51:1653-1662 https://doi.org/10.1016/j.jacc.2008.01.026
  5. Carlson LA, Böttiger LE. 1985. Risk factors for ischaemic heart disease in men and women. results of the 19-year follow-up of the Stockholm prospective study. Acta Med Scand 218:207-211 https://doi.org/10.1111/j.0954-6820.1985.tb08848.x
  6. Cho HE, Choi YH, Park SH, Park YS, Ahn BY. 2008. Effect of Gastrodiae rhizoma power on serum and liver lipid levels of rats with high fat diet. Korean J Food & Nutr 21:64-70
  7. Cho JW, Lee KS. 2009. Anti-inflammatory effect of curcumin on UVB-induced inflammatory cytokines in HaCaT cells. Korean J Dermatol 47:121-126
  8. Choi KH, Choi SN, Choo JJ, Lee JY, Kim JY, Kim JW, Choi JS, Park KS, Park KH. 2007. Tissue concentration of quercetin, isoquercitirin and hyperoside, and lipid profile changes following 8-week feeding of Angelica keiskei power in rats. Korean J Food Sci Technol 39:721-724
  9. Dietschy JM, Turley SD, Spady DK. 1993. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 34:1637-1659
  10. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, ItabeH, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. 2001. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103:1955-1960 https://doi.org/10.1161/01.CIR.103.15.1955
  11. Fujita T, Sakuma S, Sumiya T, Nishida H, Fujimoto Y, Baba K, Kozawa M. 1992. The effects of xanthoangelol E on arachidonic acid metabolism in the gastric antral mucosa and platelet of the rabbit. Res Commun Chem Pathol Pharmacol 77:227-240
  12. Grundy SM. 1992. Cholesterol-lowering drugs as cardioprotective agents. Am J Cardiol 70:27I-32I https://doi.org/10.1016/0002-9149(92)90262-W
  13. Huang HC, Jan TR, Yeh SF. 1992. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 221:381-384 https://doi.org/10.1016/0014-2999(92)90727-L
  14. Johansson S, Wilhelmsen L, Lappas G, Rosengren A. 2003. High lipid levels and coronary disease in women in Göteborgoutcome and secular trends: a prospective 19 year follow-up in the BEDA-study. Eur Heart J 24:704-716 https://doi.org/10.1016/S0195-668X(02)00811-4
  15. Kesäniemi YA, Miettinen TA. 1987. Cholesterol absorption efficiency regulates plasma cholesterol level in the finnish population. Eur J Clin Invest 17:391-395 https://doi.org/10.1111/j.1365-2362.1987.tb01132.x
  16. Kim AJ, Park SJ, Rho JO. 2008a. Mulberry fruit extract consumption is inversely associated with hyperlipidemia in middle-aged men. Korean J Food & Nutr 21:121-126
  17. Kim JS, Kim HY, Park YK, Kim TS, Kang MH. 2003. The effects of green vegetable juice (Angelica keiskei) supplements on plasma lipids and antioxidant status in smokers. Korean J Nutr 36:933-941
  18. Kim TH, Son YK, Hwang KH, Kim MH. 2008b. Effects of Angelica keiskei Koidwumi and turmeric extract supplementation on serum lipid parameters in hypercholesterolemic diet or P-407-induced hyperlipidemic rats. J Korean Soc Food Sci Nutr 37:708-713 https://doi.org/10.3746/jkfn.2008.37.6.708
  19. Korean guideline of hyperlipidemia treatment for prevention of atherosclerosis. 2003. Korean Society of Lipidology and Athrosclerosis
  20. Kwak HK, Kim MJ. 2009. Age-related circulating inflammatory markers and cardiavascular disease risk factors in Korean women. Korean J Comm Nutr 14:451-461
  21. Lee SK, Kim GM, Mun YS. 1994. Comparative effects of overweight on serum lipid profile in younger versus older men. J Korean Acad Fam Med 15:511-524
  22. Miller GJ, Miller NE. 1975. Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet 1:16-19 https://doi.org/10.1016/S0140-6736(02)95332-8
  23. Ogawa H, Nakamura R, Baba K. 2005. Beneficial effect of laserpitin, a coumarin compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 32:1104-1109 https://doi.org/10.1111/j.1440-1681.2005.04306.x
  24. Ogawa H, Nakashima S, Baba K. 2003. Effects of dietary Angelica keiskei on lipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 30:284-288 https://doi.org/10.1046/j.1440-1681.2003.03830.x
  25. Ogawa H, Ohno M, Baba K. 2005. Hypotensive and lipid regulatory actions of 4-hydroxyderricin, a chalcone from Angelica keiskei, in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 32:19-23 https://doi.org/10.1111/j.1440-1681.2005.04147.x
  26. Ogawa H, Okada Y, Kamisako T, Baba K. 2007. Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, onlipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 34:238-243 https://doi.org/10.1111/j.1440-1681.2007.04578.x
  27. Oh PS, Lee SJ, Lim KT. 2006. Hypolipidemic and antioxidative effects of the plant glycoprotein (36 kDa) from Rhus verniciflua stokes fruit in Triton WR-1339-induced hyperlipidemic mice. Biosci Biotechnol Biochem 70:447-456 https://doi.org/10.1271/bbb.70.447
  28. Park JC, Cho YS, Park SK, Park JR, Chun SS, Ok KD, Choi JW. 1995. Isolation of flavone-7-O-glycosides from the aerial parts of Angelica keiskei and anti hyperlipidemic effect. Korean J Pharmacogn 26:337-343
  29. Park JR, Park JC, Choi SH. 1997b. Screening and characterization of anticholesterolgenic substances from edible plant extracts. J Korean Soc Food Sci Nutr 26:236-241
  30. Park JR, Park SK, Cho YS, Chun SS, Choi SH, Park JC. 1997a. Effects of Angelica keiskei on lipid matabolism in rats. J Korean Soc Food Sci Nutr 26:308-313
  31. Pingali H, Jain M, Shah S, Basu S, Makadia P, Goswami A, Zaware P, Patil P, Godha A, Giri S, Goel A, Patel M, Patel H, Patel P. 2008. Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent. Bioorg Med Chem Lett 18:5586-5590 https://doi.org/10.1016/j.bmcl.2008.08.112
  32. Yagi, K. 1998. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Free Radical and Antioxidant Protocols 108:101-106 https://doi.org/10.1385/0-89603-472-0:101
  33. Ram$\acute{l}$ rez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Bar$\acute{o}$ L, Ramirez-Tortosa CL, Martinez-Victoria E, Gil A. 1999. Oral administration of turmeric extract inhibit LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147:371-378 https://doi.org/10.1016/S0021-9150(99)00207-5
  34. Rao DS, Sekhara NC, Satyanarayana MN, Srinivasan M. 1970. Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr 100:1307-1315 https://doi.org/10.1093/jn/100.11.1307
  35. Shimada K, Mokuno H, Matsunaga E, Miyazaki T, Sumiyoshi K, Miyauchi K, Daida H. 2004. Circulating oxidized lowdensity lipoprotein is an independent predictor forcardiac event in patients with coronary artery disease. Atherosclerosis 174:343-347 https://doi.org/10.1016/j.atherosclerosis.2004.01.029
  36. Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P. 2007. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther 29:253-260 https://doi.org/10.1016/j.clinthera.2007.02.008
  37. Soni KB, Kuttan R. 1992. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36:273-275
  38. Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, Nagai R, SuzukiT, Amaki T, Nagai R, Hasegawa A, Toshima S, Kurabayashi MH, Shimada K, Nakamura H, Teramoto T, Yamaguchi H, Nishiyama S, Takahashi H, Michishita I, Sugano Z, Konoshi K. 2002. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 35:347-353 https://doi.org/10.1016/S0009-9120(02)00326-0
  39. Thompson PD, Clarkson P, Karas RH. 2003. Statin-associated myopathy. JAMA 289:1681-1690 https://doi.org/10.1001/jama.289.13.1681
  40. Warstedt K, Furuhjelm C, Duch$\acute{e}$n K, F$\ddot{a}$lth-Magnusson K, Fager$\aa$s M. 2009. The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatr Res 66:212-217 https://doi.org/10.1203/PDR.0b013e3181aabd1c
  41. Yang X, Thomas DP, Zhang X, Culver BW, Alexander BM, Murdoch WJ, Rao MN, TulisDA, Ren J, Sreejayan N. 2006. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol 26:85-90 https://doi.org/10.1161/01.ATV.0000191635.00744.b6
  42. Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris- Etherton PM. 2007. Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr 85:385-391 https://doi.org/10.1093/ajcn/85.2.385